Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.
Murria R, Palanca S, de Juan I, Alenda C, Egoavil C, Seguí FJ, García-Casado Z, Juan MJ, Sánchez AB, Segura Á, Santaballa A, Chirivella I, Llop M, Pérez G, Barragán E, Salas D, Bolufer P. Murria R, et al. Among authors: sanchez ab. Am J Cancer Res. 2015 Jun 15;5(7):2330-43. eCollection 2015. Am J Cancer Res. 2015. PMID: 26328265 Free PMC article.
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I, Palanca S, Domenech A, Feliubadaló L, Segura Á, Osorio A, Chirivella I, de la Hoya M, Sánchez AB, Infante M, Tena I, Díez O, Garcia-Casado Z, Vega A, Teulé À, Barroso A, Pérez P, Durán M, Carrasco E, Juan-Fita MJ, Murria R, Llop M, Barragan E, Izquierdo Á, Benítez J, Caldés T, Salas D, Bolufer P. de Juan I, et al. Among authors: sanchez ab. Fam Cancer. 2015 Dec;14(4):505-13. doi: 10.1007/s10689-015-9814-z. Fam Cancer. 2015. PMID: 26026974
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS).
Ramírez-Calvo M, García-Casado Z, Fernández-Serra A, de Juan I, Palanca S, Oltra S, Soto JL, Castillejo A, Barbera VM, Juan-Fita MJ, Segura Á, Chirivella I, Sánchez AB, Tena I, Chaparro C, Salas D, López-Guerrero JA. Ramírez-Calvo M, et al. Among authors: sanchez ab. Hered Cancer Clin Pract. 2019 Jan 18;17:3. doi: 10.1186/s13053-019-0104-x. eCollection 2019. Hered Cancer Clin Pract. 2019. PMID: 30675318 Free PMC article.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Amphibian tolerance to arsenic: microbiome-mediated insights.
Cordeiro IF, Lemes CGC, Sanchez AB, da Silva AK, de Paula CH, de Matos RC, Ribeiro DF, de Matos JP, Garcia CCM, Beirão M, Becker CG, Pires MRS, Moreira LM. Cordeiro IF, et al. Among authors: sanchez ab. Sci Rep. 2024 May 3;14(1):10193. doi: 10.1038/s41598-024-60879-w. Sci Rep. 2024. PMID: 38702361 Free PMC article.
Diagnostic challenges of recurrent malaria in non-endemic areas†.
Ramirez-Hidalgo MF, González EL, Moles SI, García CA, Muñoz JMR, Ortega RL, Navés LG, Sánchez AB, Jover-Sáenz A. Ramirez-Hidalgo MF, et al. Among authors: sanchez ab. J Travel Med. 2024 Apr 6;31(3):taae041. doi: 10.1093/jtm/taae041. J Travel Med. 2024. PMID: 38457638 No abstract available.
64 results